Peak Month$
| RSV group A§
| RSV group B§
|
|---|
|  | Identified (%)* | Sequenced | Unique (%) | % GD¶
| Identified | Sequenced | Unique (%) | %GD¶
|
|---|
Jan 2008#
| 6 (14) | 3 | 2 (67) | 4.3 | 36 | 24 | 9 (38) | 1.0 |
Jun 2008 | 34 (100) | 22 | 10 (45) | 5.9 | 0 | - | - | - |
Dec 2008#
| 66 (100) | 66 | 12 (18) | 0.6 | 0 | - | - | - |
Jun 2009 | 29 (94) | 24 | 13 (54) | 0.7 | 2 | 2 | 2 (100) | 1.8 |
Dec 2009#
| 56 (100) | 52 | 15 (29) | 0.7 | 0 | - | - | - |
Mar 2011#
| 7 (8) | 8 | 4 (50) | 0.2 | 78 | 76 | 25 (33) | 2.6 |
Inter-epidemic | 8 (53) | 7 | 6 (86) | 2.7 | 7 | 6 | 5 (83) | 2.4 |
Total§
| 206 (65.6) | 182 | 62 (34.1) | 2.4 | 123 | 108 | 41 (38.0) | 2.6 |
-
$refers to the peak epidemic months of the epidemic periods we defined (see methods and Figure 2); January 2008 - span December 2007 to February 2008, June 2008 – span April 2008 to September 2008, December 2008 – span November 2008 to March 2009, June 2009 – span April 2009 to August 2009, December 2009 – span November 2009 to January 2010, Mar 2011 – span December 2010 to August 2011. Inter-epidemic period cases were causes observed outside the above defined epidemic periods and these occurred between March 2010 and October 2010, and October and November 2011.
-
#refers to the major epidemic peak month.
-
§The numbers in the respective column of RSV group A and group B include 5 co-infections, thus the number identified and in total are increased by 5 over numbers of mono-infections referred to in the text. Only Group A viruses were possible to sequence from co-infections hence numbers of Group A sequenced are also 5 more than for mono-infections alone.
- *% Percentage of total group A and B identified that were group A.
-
¶refers to the average % genetic distance between the unique sequences which represent the % of nucleotide changes per every 100 nucleotides in the region between any the unique sequences.
